We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBP:NYSEInstalled Building Products, Inc. Analysis

Data as of 2026-04-09 - not real-time

$281.25

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Installed Building Products is trading at $281.25, comfortably above its 200‑day SMA (≈$263) but still below the 50‑day SMA (≈$298), indicating a neutral to slightly bullish medium‑term bias. Momentum indicators are mixed – the RSI sits near 51 (neutral) while the MACD histogram is positive, signaling short‑term bullish pressure. The stock carries a forward PE of ~23x and a trailing PE of ~29x, well above the sector average, and a price‑to‑book of over 10x, suggesting the market is pricing in strong growth expectations. Fundamentally, the company posts an impressive ROE of ~37% and a solid dividend yield of 1.17% with a payout ratio under 33%, supporting dividend sustainability.
Recent earnings beat estimates and the announcement of three acquisitions adding >$22 million of annual revenue have reinforced optimism, reflected in analyst median price targets around $310 – roughly a 10% upside. However, high 30‑day volatility (~49%), a beta above 1, and a debt‑to‑equity ratio exceeding 130% raise concerns about risk, especially given the consumer‑cyclical nature of the residential construction sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Positive MACD histogram and earnings beat signal near‑term strength
  • Current price near resistance level (~$292) limits upside
  • High volatility and decreasing volume increase short‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Acquisition‑driven revenue expansion adding >$22 M annually
  • Analyst median target of $310 implies ~10% upside
  • Strong ROE and sustainable dividend support valuation premium

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistently high profitability margins and cash flow generation
  • Dividend yield with low payout ratio offers income stability
  • Diversified product portfolio mitigates cyclical housing slowdown risk

Key Metrics & Analysis

Financial Health

Revenue Growth-0.40%
Profit Margin8.93%
P/E Ratio28.9
ROE37.51%
ROA11.77%
Debt/Equity139.70
P/B Ratio10.6
Op. Cash Flow$371.4M
Free Cash Flow$305.4M

Technical Analysis

TrendNeutral
RSI50.8
Support$252.58
Resistance$292.09
MA 20$271.55
MA 50$298.29
MA 200$262.70
MACDBullish
VolumeDecreasing
Fear & Greed Index84.13

Valuation

Fair Value$127.61
Target Price$303.83
Upside/Downside8.03%
GradeOvervalued
TypeGrowth
Dividend Yield1.17%

Risk Assessment

Beta1.17
Volatility48.94%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.